financetom
Business
financetom
/
Business
/
Ratan Tata alleges attempt by Mistry family to wrest control of Tata Sons
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ratan Tata alleges attempt by Mistry family to wrest control of Tata Sons
Jul 10, 2020 11:46 AM

In the ongoing tussle, in Supreme Court, between that Tata Group and Cyrus Mistry, the Chairman Emeritus of Tata Sons, Ratan N Tata has fired back arguing that he had “no hesitation” in saying that through this case, the Mistry family is seeking to gain a controlling hand in the management of Tata Sons. He further alleged that the Mistry family, acting through Cyrus Mistry, is seeking to undermine the rights of Tata Trusts as shareholders of Tata Sons.

Share Market Live

NSE

Ratan Tata has urged the apex court to look through the “smokescreen” of corporate governance, claimed by Mistry, and to examine the real intent and motives behind the plea.

In December of 2019, NCLAT had reinstated Cyrus Mistry as Chairperson of Tata Sons and had upheld charges of oppression of minority shareholders. Tata Sons challenge it before the Supreme Court. The top court, in Jan, had stayed the NCLAT judgment. In May, Cyrus Mistry also challenged the NCLAT judgment. In the cross-appeal, Cyrus Mistry has sought for “proportionate representation” for the Pallonji Group, on the Tata Sons Board. Mistry claims a “Quasi-Partnership” between the two groups. Ratan Tata has filed his reply to the cross-appeal.

In his reply, Ratan Tata argues that the conduct of Cyrus Mistry is deplorable and personally motivated. He expressed sadness at Mistry using letters exchanged between him and Cyrus Mistry’s father, as legal contracts, to “bargain a seat” on the Board.

Rata Tata has submitted that the deep hostility and personal enmity shown by Cyrus Mistry made it clear that he had become a “Trojan Horse”, who had to be removed in the interest of the Group. He also alleged that Mistry cherry picked information and sensationalized financial health issues to cause instability in Tata Group Cos.

Responding to claims of a “quasi partnership” between Tata and Pallonji Group, Ratan Tata denied that any such partnership existed. He has pleaded that Mistry’s claims of quasi partnership with Tata’s is conceptually flawed and baseless.

Tata submits that in 1965 the Pallonji Group bought 124 shares based on commercial merit, and that no further rights flowed from the share purchase. He argues that Mistry is misinterpreting and mischaracterizing commercial decisions of the Pallonji group, to engage with Tata’s. He urges that it would be “ludicrous” to suggest that there was a joint venture or partnership between Tata and Mistry. He argues in his reply, that despite “legal acrobatics”, merely shareholding can’t translate into rights of a quasi-partnership. He also submits that even under the Companies Act there was no obligation to provide “proportionate representation” and that the Articles of Association were silent on the issue.

Ratan Tata also rejected allegations that he orchestrated Mistry’s removal as Chairperson, due to “insecurities”. His reply argues that Mistry removal was an urgent and remedial measure taken in larger interest of the group. He further urges that the Tata Sons board consisting of a Former Ambassador, Defence Secretary and Dean of Harvard, had voted in favor of removing Mistry. He argues that Mistry could be free to disagree with the Board’s decision, but should have respected it.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MIRA Pharmaceuticals Selects Neuropathic Pain as Initial Indication of Ketamir-2
MIRA Pharmaceuticals Selects Neuropathic Pain as Initial Indication of Ketamir-2
Sep 11, 2024
08:07 AM EDT, 09/11/2024 (MT Newswires) -- MIRA Pharmaceuticals ( MIRA ) said Wednesday it has selected neuropathic pain as the initial and primary indication for its new oral ketamine analog, Ketamir-2. The company said it has submitted a request for a pre-investigational New Drug meeting with the US Food and Drug Administration, which is expected to occur in November....
Blackline Safety's Fiscal Q3 Loss Narrows on Record Revenue
Blackline Safety's Fiscal Q3 Loss Narrows on Record Revenue
Sep 11, 2024
08:07 AM EDT, 09/11/2024 (MT Newswires) -- Blackline Safety ( BLKLF ) said Wednesday that its net loss for third quarter narrowed as the company booked record revenue. For the three months ended July 31, the company posted a net loss of $2.5 million, or $0.03 per share, compared with a loss of $6.8 million, or $0.09 per share. Analysts...
Bank of Canada Needs to Step Up The Easing Pace, Says National Bank
Bank of Canada Needs to Step Up The Easing Pace, Says National Bank
Sep 11, 2024
08:09 AM EDT, 09/11/2024 (MT Newswires) -- Some forecasters, including the Bank of Canada, had high hopes of an economic recovery and a stabilization of the unemployment rate in the second half of the year, in the wake of interest rate cuts, noted National Bank of Canada. For several months now, the bank said it has been arguing that, although...
US LNG feedgas dips ahead of Hurricane Francine on reductions at Louisiana plants
US LNG feedgas dips ahead of Hurricane Francine on reductions at Louisiana plants
Sep 11, 2024
Sept 11 (Reuters) - The amount of natural gas flowing to U.S. liquefied natural gas (LNG) export plants was on track to dip to a two-week low on Wednesday as energy firms cut back on feedgas to their plants in Louisiana before Hurricane Francine crashes into the state's coast, according to data from financial firm LSEG. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved